Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

1.1K
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
1.1K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.9K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

1.5K
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
1.5K
Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

558
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
558
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

600
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
600
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

115
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gadolinium toxicity: mechanisms, clinical manifestations, and nanoparticle role.

Archives of toxicology·2025
Same author

Erratum for: CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.

Radiology·2025
Same author

Tumor specific delivery and radiation-enhanced tumor penetration of mesoporous silica nanoparticles for effective radionuclide therapy of ovarian peritoneal metastasis.

International journal of pharmaceutics·2024
Same author

Gadolinium Elimination in a Gadolinium Deposition Disease Population After a Single Exposure to Gadolinium-Based Contrast Agents.

Investigative radiology·2024
Same author

CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.

Radiology·2024
Same author

Implant dynamics, inner structure, and their impact on drug release of in situ forming implants uncovered through CT imaging.

Journal of controlled release : official journal of the Controlled Release Society·2024

Related Experiment Video

Updated: Mar 14, 2026

An Aptamer-based Sensor for Unchelated GadoliniumIII
05:15

An Aptamer-based Sensor for Unchelated GadoliniumIII

Published on: January 9, 2017

7.8K

Gadolinium toxicity and treatment.

Joana Ramalho1, Miguel Ramalho2, Michael Jay3

  • 1Department of Radiology, University of North Carolina, Chapel Hill, NC, United States; Department of Radiology, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.

Magnetic Resonance Imaging
|October 4, 2016
PubMed
Summary

Gadolinium deposition disease is a newly identified condition where gadolinium contrast agents accumulate in the body, causing symptoms like bone and skin issues. Further research is needed to understand the long-term effects of gadolinium retention.

Keywords:
Adverse eventsGadoliniumGadolinium deposition diseaseToxicityTreatment

More Related Videos

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.8K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.1K

Related Experiment Videos

Last Updated: Mar 14, 2026

An Aptamer-based Sensor for Unchelated GadoliniumIII
05:15

An Aptamer-based Sensor for Unchelated GadoliniumIII

Published on: January 9, 2017

7.8K
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.8K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.1K

Area of Science:

  • Radiology and Medical Imaging
  • Toxicology
  • Nephrology

Background:

  • Gadolinium-based contrast agents (GBCAs) are widely used in medical imaging.
  • Concerns about gadolinium retention in patients with normal renal function have resurfaced.
  • Gadolinium deposits have been detected in the brains and bones of these patients.

Purpose of the Study:

  • To review gadolinium toxicity disorders, including acute adverse reactions to GBCAs.
  • To focus on gadolinium deposition disease (GDD), a recently described condition.
  • To discuss the clinical manifestations and current understanding of GDD.

Main Methods:

  • Literature review of studies on gadolinium retention and toxicity.
  • Analysis of self-reported symptoms from patient support groups.
  • Synthesis of information on acute reactions versus chronic gadolinium deposition disease.

Main Results:

  • Gadolinium retention, termed "gadolinium storage condition," occurs even in patients with normal kidney function.
  • Patients report chronic symptoms, including bone, joint, and skin complaints, attributed to gadolinium exposure.
  • These self-reported symptoms form the basis of the newly described "gadolinium deposition disease."

Conclusions:

  • Gadolinium deposition disease represents a significant, yet poorly understood, consequence of GBCA exposure.
  • The long-term health implications of cumulative gadolinium retention require further investigation.
  • Understanding gadolinium toxicity spectrum is crucial for patient safety and clinical management.